Antimicrobial Susceptibility Profiles of Pasteurella multocida Isolates from Clinical Cases of Waterfowl in Hungary between 2022 and 2023
- PMID: 38787166
- PMCID: PMC11125817
- DOI: 10.3390/vetsci11050194
Antimicrobial Susceptibility Profiles of Pasteurella multocida Isolates from Clinical Cases of Waterfowl in Hungary between 2022 and 2023
Abstract
The waterfowl industry represents a narrow, yet economically significant, sector within the poultry industry. Although less prominent, the waterfowl sector is nonetheless of equal importance to any other livestock sector in terms of antimicrobial resistance and animal health issues. This study assesses the antimicrobial resistance profile of Pasteurella multocida bacterial strains isolated from clinical cases in Hungary's duck and goose populations, determining the minimal inhibitory concentration (MIC) of 27 samples collected from 15 different locations. The results indicate that the isolated strains were susceptible to most antibiotics, except for notable resistance to enrofloxacin. These findings support that Pasteurella multocida largely retained its susceptibility. However, the observed resistance to enrofloxacin suggests overuse of fluoroquinolones, which indicates the potential need for stricter regulation of their use in the poultry industry.
Keywords: MIC; Pasteurella multocida; antimicrobial resistance; ducks; fluoroquinolone resistant; geese; minimum inhibitory concentration; waterfowl.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures



Similar articles
-
Antimicrobial Susceptibility Profiles of Salmonella spp. Isolates from Clinical Cases of Waterfowl in Hungary Between 2022 and 2023.Microorganisms. 2024 Nov 29;12(12):2462. doi: 10.3390/microorganisms12122462. Microorganisms. 2024. PMID: 39770665 Free PMC article.
-
Antimicrobial Susceptibility Profiles of Erysipelothrix rhusiopathiae and Riemerella anatipestifer Isolates from Clinical Cases of Waterfowl in Hungary Between 2022 and 2023.Antibiotics (Basel). 2025 May 8;14(5):478. doi: 10.3390/antibiotics14050478. Antibiotics (Basel). 2025. PMID: 40426544 Free PMC article.
-
Antimicrobial Susceptibility Profiles of Staphylococcus aureus and Streptococcus spp. Isolates from Clinical Cases of Waterfowl in Hungary Between 2022 and 2023.Antibiotics (Basel). 2025 May 12;14(5):496. doi: 10.3390/antibiotics14050496. Antibiotics (Basel). 2025. PMID: 40426562 Free PMC article.
-
Antimicrobial susceptibility of Pasteurella multocida isolated from swine and poultry.Acta Vet Hung. 2009 Sep;57(3):357-67. doi: 10.1556/AVet.57.2009.3.2. Acta Vet Hung. 2009. PMID: 19635708
-
Antimicrobial resistance of Pasteurella multocida type B isolates associated with acute septicemia in pigs and cattle in Spain.BMC Vet Res. 2020 Jun 30;16(1):222. doi: 10.1186/s12917-020-02442-z. BMC Vet Res. 2020. PMID: 32605567 Free PMC article.
Cited by
-
Hemorrhagic septicemia: A major threat to livestock health.Open Vet J. 2025 Feb;15(2):519-532. doi: 10.5455/OVJ.2025.v15.i2.3. Epub 2025 Feb 28. Open Vet J. 2025. PMID: 40201842 Free PMC article. Review.
-
Evaluation of immunoprotective effects of PlpE multi-epitope protein incorporated within the aluminum hydroxide-adjuvanted inactivated vaccine against Pasteurella multocida infection in chickens.Poult Sci. 2025 Jun 14;104(9):105426. doi: 10.1016/j.psj.2025.105426. Online ahead of print. Poult Sci. 2025. PMID: 40561824 Free PMC article.
-
Antimicrobial Susceptibility Profiles of Commensal Staphylococcus spp. Isolates from Turkeys in Hungarian Poultry Farms Between 2022 and 2023.Antibiotics (Basel). 2025 Feb 14;14(2):200. doi: 10.3390/antibiotics14020200. Antibiotics (Basel). 2025. PMID: 40001443 Free PMC article.
-
Comparative Pharmacokinetics and Egg Residues of Amoxicillin, Single and in Combination with Bromhexine, in Laying Hens.Pathogens. 2024 Nov 8;13(11):982. doi: 10.3390/pathogens13110982. Pathogens. 2024. PMID: 39599535 Free PMC article.
References
-
- Sy C.L., Chen P.-Y., Cheng C.-W., Huang L.-J., Wang C.-H., Chang T.-H., Chang Y.-C., Chang C.-J., Hii I.-M., Hsu Y.-L., et al. Recommendations and Guidelines for the Treatment of Infections Due to Multidrug Resistant Organisms. J. Microbiol. Immunol. Infect. 2022;55:359–386. doi: 10.1016/j.jmii.2022.02.001. - DOI - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources